2-Heptadecylimidazole
- 中文别名:2-十七烷基咪唑
- 中文释义:2-十七烷基咪唑;2-正十七基咪唑
- 英文别名:2-heptadecyl-1H-imidazole;
1H-Imidazole,2-heptadecyl;
EINECS 245-589-7;
2-Heptadecylimidazol;
2-Heptadecyl-1H-imidazol;
2-Heptadecylimidazole;
2-Margarylimidazol
- CAS No.:23328-87-2
- 分子式:C20H38N2
- 分子量:306.53
- 精确分子量:306.30300
- PSA:28.68000
- InChI:InChI=1/C20H38N2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20-21-18-19-22-20/h18-19H,2-17H2,1H3,(H,21,22)
- 分子结构式:
物化性质
- 密度:
- 0.897 g/cm3
- 熔点:
- 89ºC
- 沸点:
- 455.5ºC at 760 mmHg
- 闪点:
- 211.7ºC
- 折射率:
- 1.484
- 蒸汽压:
- 4.74E-08mmHg at 25°C
- 存储条件/存储方法:
- 稳定性相关:
- 其它信息:
1.性状:未确定
2.密度(g/mL,25/4℃):未确定
3.相对蒸汽密度(g/mL,空气=1):未确定
4.熔点(ºC):89
5.沸点(ºC,常压):未确定
6.沸点(ºC,5.2kPa):未确定
7.折射率:未确定
8.闪点(ºC):未确定
9.比旋光度(º):未确定
10.自燃点或引燃温度(ºC):未确定
11.蒸气压(kPa,25ºC):未确定
12.饱和蒸气压(kPa,60ºC):未确定
13.燃烧热(KJ/mol):未确定
14.临界温度(ºC):未确定
15.临界压力(KPa):未确定
16.油水(辛醇/水)分配系数的对数值:未确定
17.爆炸上限(%,V/V):未确定
18.爆炸下限(%,V/V):未确定
19.溶解性:未确定
安全信息
- 密度:
- 0.897 g/cm3
- 熔点:
- 89ºC
- 沸点:
- 455.5ºC at 760 mmHg
- 闪点:
- 211.7ºC
- 折射率:
- 1.484
- 蒸汽压:
- 4.74E-08mmHg at 25°C
- 存储条件/存储方法:
- 稳定性相关:
- 其它信息:
1.性状:未确定
2.密度(g/mL,25/4℃):未确定
3.相对蒸汽密度(g/mL,空气=1):未确定
4.熔点(ºC):89
5.沸点(ºC,常压):未确定
6.沸点(ºC,5.2kPa):未确定
7.折射率:未确定
8.闪点(ºC):未确定
9.比旋光度(º):未确定
10.自燃点或引燃温度(ºC):未确定
11.蒸气压(kPa,25ºC):未确定
12.饱和蒸气压(kPa,60ºC):未确定
13.燃烧热(KJ/mol):未确定
14.临界温度(ºC):未确定
15.临界压力(KPa):未确定
16.油水(辛醇/水)分配系数的对数值:未确定
17.爆炸上限(%,V/V):未确定
18.爆炸下限(%,V/V):未确定
19.溶解性:未确定
MSDS
Section I.Chemical Product and Company Identification
Chemical Name 2-Heptadecylimidazole
Portland OR
SynonymNot available.
Chemical FormulaC20H38N2
CAS Number23328-87-2
Section II.Composition and Information on Ingredients
Chemical NameCAS Number Percent (%)TLV/PELToxicology Data
2-Heptadecylimidazole23328-87-2---------- Not available.Not available.
Section III. Hazards Identification
Acute Health EffectsNo specific information is available in our data base regarding the toxic effects of this material for humans. However,
exposure to any chemical should be kept to a minimum. Skin and eye contact may result in irritation. May be harmful if
inhaled or ingested. Always follow safe industrial hygiene practices and wear proper protective equipment when handling
this compound.
CARCINOGENIC EFFECTS : Not available.
Chronic Health Effects
MUTAGENIC EFFECTS : Not available.
TERATOGENIC EFFECTS : Not available.
DEVELOPMENTAL TOXICITY: Not available.
There is no known effect from chronic exposure to this product. Repeated or prolonged exposure to this compound is
not known to aggravate existing medical conditions.
Section IV.First Aid Measures
Eye ContactCheck for and remove any contact lenses. DO NOT use an eye ointment. Flush eyes with running water for a minimum
of 15 minutes, occasionally lifting the upper and lower eyelids. Seek medical attention. Treat symptomatically and
supportively.
Skin ContactIf the chemical gets spilled on a clothed portion of the body, remove the contaminated clothes as quickly as possible,
protecting your own hands and body. Place the victim under a deluge shower. If the chemical touches the victim's
exposed skin, such as the hands: Gently and thoroughly wash the contaminated skin with running water and non-abrasive
soap. Be particularly careful to clean folds, crevices, creases and groin. Cover the irritated skin with an emollient. Seek
medical attention. Treat symptomatically and supportively. Wash any contaminated clothing before reusing.
InhalationIf the victim is not breathing, perform artificial respiration. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, oxygen can be administered. Seek medical attention. Treat symptomatically and supportively.
IngestionINDUCE VOMITING by sticking finger in throat. Lower the head so that the vomit will not reenter the mouth and throat.
Loosen tight clothing such as a collar, tie, belt, or waistband. If the victim is not breathing, administer artificial respiration.
Examine the lips and mouth to ascertain whether the tissues are damaged, a possible indication that the toxic material
was ingested; the absence of such signs, however, is not conclusive. Loosen tight clothing such as a collar, tie, belt or
waistband. If the victim is not breathing, perform artificial respiration. Seek immediate medical attention and, if possible,
show the chemical label. Treat symptomatically and supportively.
Section V. Fire and Explosion Data
Auto-IgnitionNot available.
FlammabilityCombustible.
Flash PointsFlammable LimitsNot available.
245°C (473°F).
Combustion ProductsThese products are toxic carbon oxides (CO, CO 2), nitrogen oxides (NO, NO2).
Fire Hazards
No specific information is available regarding the flammability of this compound in the presence of various materials.
Risks of explosion of the product in presence of mechanical impact: Not available.
Explosion Hazards
Risks of explosion of the product in presence of static discharge: Not available.
No additional information is available regarding the risks of explosion.
Continued on Next Page
2-Heptadecylimidazole
Fire Fighting Media
SMALL FIRE: Use DRY chemicals, CO 2, water spray or foam.
and InstructionsLARGE FIRE: Use water spray, fog or foam. DO NOT use water jet.
Section VI.Accidental Release Measures
Spill CleanupIn case of a spill and/or a leak, always shut off any sources of ignition, ventilate the area, and exercise caution. Use a
Instructionsshovel to put the material into a convenient waste disposal container. Finish cleaning the spill by rinsing any
contaminated surfaces with copious amounts of water. Consult federal, state, and/or local authorities for assistance on
disposal.
Section VII. Handling and Storage
Handling and StorageKeep away from heat and sources of ignition. Mechanical exhaust required. When not in use, tightly seal the container
and store in a dry, cool place. Avoid excessive heat and light. DO NOT breathe dust. In case of insufficient ventilation,
Information
wear suitable respiratory equipment. If you feel unwell, seek medical attention and show the label when possible. Treat
symptomatically and supportively. Avoid contact with skin and eyes.
Always store away from incompatible compounds such as oxidizing agents.
Section VIII. Exposure Controls/Personal Protection
Engineering ControlsUse process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal ProtectionSplash goggles. Lab coat. Dust respirator. Boots. Gloves. A MSHA/NIOSH approved respirator must be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling
this product.
Exposure LimitsNot available.
Section IX. Physical and Chemical Properties
Physical state @ 20°CCrystalline powder.Solubility
Not available.
Specific GravityNot available.
Molecular Weight306.54Partition CoefficientNot available.
Boiling Point
Not available.Vapor PressureNot available.
Melting Point89°C (192.2°F)Vapor DensityNot available.
Refractive IndexNot available.VolatilityNot available.
Critical TemperatureNot available.OdorNot available.
ViscosityNot available.TasteNot available.
Section X.Stability and Reactivity Data
StabilityThis material is stable if stored under proper conditions. (See Section VII for instructions)
Conditions of InstabilityAvoid excessive heat and light.
Incompatibilities
Reactive with oxidizing agents.
Section XI. Toxicological Information
RTECS NumberNot available.
Eye contact. Inhalation. Ingestion.
Routes of Exposure
Toxicity DataNot available.
Chronic Toxic EffectsCARCINOGENIC EFFECTS : Not available.
MUTAGENIC EFFECTS : Not available.
TERATOGENIC EFFECTS : Not available.
DEVELOPMENTAL TOXICITY: Not available.
There is no known effect from chronic exposure to this product. Repeated or prolonged exposure to this compound is not
known to aggravate existing medical conditions.
Acute Toxic EffectsNo specific information is available in our data base regarding the toxic effects of this material for humans. However,
exposure to any chemical should be kept to a minimum. Skin and eye contact may result in irritation. May be harmful if
inhaled or ingested. Always follow safe industrial hygiene practices and wear proper protective equipment when handling
this compound.
Continued on Next Page
2-Heptadecylimidazole
Section XII.Ecological Information
EcotoxicityNot available.
Environmental FateNot available.
Section XIII. Disposal Considerations
Recycle to process, if possible. Consult your local or regional authorities. You may be able to dissolve or mix material with
Waste Disposal
a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system. Observe all
federal, state, and local regulations when disposing of this substance.
Section XIV. Transport Information
DOT ClassificationNot a DOT controlled material (United States).
PIN NumberNot applicable.
Proper Shipping Name
Not applicable.
Packing Group (PG)Not applicable.
DOT Pictograms
Section XV. Other Regulatory Information and Pictograms
TSCA Chemical InventoryThis product is ON the EPA Toxic Substance Control Act (TSCA) inventory.
(EPA)
WHMIS Classification
Not controlled under WHMIS (Canada).
(Canada)
EINECS Number (EEC) 245-589-7
EEC Risk StatementsNot available.
SECTION 16 - ADDITIONAL INFORMATION
N/A
海关数据
中国海关编码:2933290090
- 概述:
- 2933290090. 其他结构含非稠合咪唑环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
- 申报要素:
- 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
- 摘要/Summary:
- 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
分子结构与计算化学数据
分子结构数据
五、分子性质数据:
1、 摩尔折射率:97.81
2、 摩尔体积(cm3/mol):341.3
3、 等张比容(90.2K):834.3
4、 表面张力(dyne/cm):35.6
5、 极化率(10-24cm3):38.77
计算化学数据
1.疏水参数计算参考值(XlogP):8.8
2.氢键供体数量:1
3.氢键受体数量:1
4.可旋转化学键数量:16
5.互变异构体数量:2
6.拓扑分子极性表面积28.7
7.重原子数量:22
8.表面电荷:0
9.复杂度:218
10.同位素原子数量:0
11.确定原子立构中心数量:0
12.不确定原子立构中心数量:0
13.确定化学键立构中心数量:0
14.不确定化学键立构中心数量:0
15.共价键单元数量:1
热门化工词典词汇
- 3-Pyridinemethanol,5,6-dichloro-5,6-二氯-3-嘧啶甲醇
- 4-(6-Methoxy-pyriMidin-4-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester4-(6-甲氧基-嘧啶-4-基氨基)-哌啶-1-羧酸叔丁基酯
- 5-(1-ethyl-5-methylpyrazol-4-yl)-1,2-oxazole-3-carboxylic acid5-(1-乙基-5-甲基-1H-吡唑-4-基)-异恶唑-3-羧酸
- 2-Propenoicacid,2-hydroxyethylester,polymerwith.alpha.-hydro-.omega.-hydroxypoly(oxy-1,4-butanediyl)and1,1-methylenebis[42-丙烯酸-2-羟乙基酯与&alpha
- dimethyl bicyclo[2.2.1]heptane-2,3-dicarboxylatedimethyl bicyclo[2.2.1]heptane-2,3-dicarboxylate
- 5-methylsulfonylthiophene-2-carbaldehyde5-(甲基磺酰基)-2-噻吩甲醛
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-methyl-5-METHYLPYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE
- 1-bromo-6-methylcyclohexene1-溴-6-甲基环己烯
- 3,4-dibromonaphthalene-1,2-dione3,4-二溴-1,2-萘二酮
- 1,1'-(1,3-Propanediyl)bis[1,1-bis(2-methoxy-5-methylphenyl)phosphine]1,1'-(1,3-丙二基)双[1,1-双(2-甲氧基-5-甲基苯基)膦]